EUVIMEDEUVIMED entdecken
Editorial

Therapeutic Advances and Clinical Perspectives of IL ‐1 Target Therapy in Autoinflammatory Disease

Chufan Qu iD, Meiping Lu iD

International Journal of Rheumatic Diseases · 2026-11 · 29 (11)

DOI: 10.1111/1756-185x.70909 ↗

Kurz gefasst

Editorial in der Zeitschrift International Journal of Rheumatic Diseases, online erschienen am 02.11.2026. Verfasst von Chufan Qu und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Rheumatology Immunology & Allergy, Children's Hospital, Zhejiang University School of Medicine, Hangzhou, China. Die Arbeit nennt 8 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Autor:innen und Institutionen

  • Department of Rheumatology Immunology & Allergy, Children's Hospital, Zhejiang University School of Medicine, Hangzhou, China.

ORCID-Profile: Chufan Qu, Meiping Lu

Zitieren

APA

Qu, C., & Lu, M. (2026). Therapeutic Advances and Clinical Perspectives of IL ‐1 Target Therapy in Autoinflammatory Disease. International Journal of Rheumatic Diseases, 29(11). https://doi.org/10.1111/1756-185x.70909

Vancouver

Qu C, Lu M. Therapeutic Advances and Clinical Perspectives of IL ‐1 Target Therapy in Autoinflammatory Disease. International Journal of Rheumatic Diseases. 2026;29(11). doi:10.1111/1756-185x.70909

BibTeX
@article{Qu2026,
  author = {Qu, Chufan and Lu, Meiping},
  title = {Therapeutic Advances and Clinical Perspectives of IL ‐1 Target Therapy in Autoinflammatory Disease},
  journal = {International Journal of Rheumatic Diseases},
  year = {2026},
  volume = {29},
  number = {11},
  doi = {10.1111/1756-185x.70909}
}
Kostenlos starten →